3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Breast Neoplasms
15
Stomatitis
14
Head and Neck Neoplasms
14
Neoplasms
7
Radiodermatitis
6
Lymphedema
6
Mucositis
5
Xerostomia
4
Trismus
3
Ulcer
2
Squamous Cell Carcinoma of Head and Neck
2
Radiation Injuries
2
Peripheral Nervous System Diseases
2
Hematologic Neoplasms
2
Fibrosis
2
Dermatitis
2
Breast Cancer Lymphedema
2
Wounds and Injuries
1
Taste Disorders
1
Skin Diseases
1
Radiation Induced Xerostomia
1
Radiation Fibrosis Syndrome
1
Pain
1
Ovarian Neoplasms
1
Oral Ulcer
1
Neuralgia
1
Mouth Neoplasms
1
Hand-Foot Syndrome
1
Graft vs Host Disease
1
Gastrointestinal Neoplasms
1
Interventions
Cisplatin
30
Magnetic Resonance Spectroscopy
21
Radiotherapy
20
pembrolizumab
18
Specimen Handling
17
Cetuximab
16
Radiotherapy, Intensity-Modulated
11
Paclitaxel
11
Carboplatin
11
Fluorouracil
10
Biopsy
10
1,2-diaminocyclohexaneplatinum II citrate
10
Radiation
9
Platinum
9
Drug Therapy
9
Taxes
7
Surgical Procedures, Operative
7
Celecoxib
7
X-Rays
6
Standard of Care
6
Sentinel Lymph Node Biopsy
6
Surveys and Questionnaires
5
Nivolumab
5
cemiplimab
4
Metformin
4
Fluorodeoxyglucose F18
4
Docetaxel
4
Chemoradiotherapy
4
(225)Ac-DOTA-c(RGDyK)
4
durvalumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Mouth Neoplasms
×
Low-Level Light Therapy
×
Clear all
NCT07387978
2026-02-04
PBM
Peter MacCallum Cancer Centre, Australia
Phase NA
Recruiting
30 enrolled